Willemien Menke-van der Houven van Oordt

DR.

20142019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2014 2019

89 Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo

Jauw, Y., o'Donoghue, J., Zijlstra, J., Hoekstra, O., Menke-van der Houven van Oordt, C. W., Morschhauser, F., Carrasquillo, J., Zweegman, S., Pandit-Taskar, N., Lammertsma, A., van Dongen, G., Boellaard, R., Weber, W. & Huisman, M., 30 May 2019, In : Journal of Nuclear Medicine. p. jnumed.118.224568

Research output: Contribution to journalArticleAcademicpeer-review

89Zr-labeled bispecific T-cell engager AMG 211 PET shows AMG 211 accumulation in CD3-rich tissues and clear, heterogeneous tumor uptake

Moek, K. L., Waaijer, S. J. H., Kok, I. C., Suurs, F. V., Brouwers, A. H., Menke-van der Houven van Oordt, C. W., Wind, T. T., Gietema, J. A., Schröder, C. P., Mahesh, S. V. K., Jorritsma-Smit, A., Lub-de Hooge, M. N., Fehrmann, R. S. N., de Groot, D. J. A. & de Vries, E. G. E., 2019, In : Clinical Cancer Research. 25, 12, p. 3517-3527

Research output: Contribution to journalArticleAcademicpeer-review

89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding

van Brummelen, E. M. J., Huisman, M. C., de Wit-van der Veen, L. J., Nayak, T. K., Stokkel, M. P. M., Mulder, E. R., Hoekstra, O. S., Vugts, D. J., Van Dongen, G. A. M. S., Verheul, H. M., Evers, S., Tessier, J. J. L., Saro, J., Schellens, J. H. M. & Menke-van der Houven van Oordt, C. W., 15 May 2018, In : Oncotarget. 9, 37, p. 24737-24749 13 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access